FDA Clears Aqualung’s Phase 2a Study in Lung Fibrosis
December 22, 2025 | Juno Beach, Florida — Aqualung Therapeutics announced that the U.S. Food and Drug Administration (FDA)...
cGxP
Advertisement
FDA Approves Abbott Volt™ PFA System for Atrial Fibrillation
December 22, 2025 | Abbott Park, Illinois — Abbott announced that the U.S. Food and Drug Administration (FDA) has...
BMS–U.S. Pact Expands Access to Eliquis for Americans
December 19, 2025 | Princeton, New Jersey — Bristol Myers Squibb announced a landmark agreement with the U.S. government...
France Grants Compassionate Access to Gene Therapy LUMEVOQ®
December 22, 2025 | Paris, France — GenSight Biologics announced that France’s medicines safety authority has granted Compassionate Use...
Wasatch, Agilent Advance Native-Read Targeted Sequencing
December 19, 2025 | Salt Lake City, Utah — Wasatch BioLabs announced a co-marketing agreement with Agilent Technologies to...
Advertisements
FDA Clears Allogeneic CAR-T MT027 for Phase II Glioblastoma
December 21, 2025 | Beijing, China — T-MAXIMUM Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has...
Sharp Therapeutics Strengthens Path to Gaucher Trials
December 19, 2025 | Pittsburgh, Pennsylvania and Toronto, Ontario — Sharp Therapeutics Corp. has announced an updated non-brokered private...
Cogent Biosciences Secures $475M to Advance Precision Therapies
Dateline — WALTHAM, Mass. and BOULDER, Colo., November 11, 2025:Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company developing precision...
IN8bio Reports Strong Q3 Progress in Gamma-Delta T Cell R&D
NEW YORK, November 6, 2025 — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing gamma-delta (γδ) T cell...
Tosoh Bioscience Gains FDA 510(k) Clearance for Rapid GR01 HbA1c Analyzer
Grove City, Ohio – October 30, 2025 — Tosoh Bioscience, Inc., a global leader in clinical diagnostics and laboratory...
Advertisement
